Vireo Growth Inc. 8-K

What Happened Vireo Growth Inc. announced on June 5, 2026 that it closed the acquisition of 100% of the partnership and membership interests in Agribusiness Holdings → BWAB Holdings → Bridgewell Agribusiness LLC. The deal was structured with a stated base purchase price of US$40.0 million but, after adjustments for assumed indebtedness and transaction items, the closing purchase price was approximately US$13.66 million. At closing, Vireo issued unsecured, subordinated convertible promissory notes to the sellers in lieu of cash consideration and assumed existing indebtedness of the acquired businesses.

Key Details

• Closing date: June 5, 2026.
• Stated base purchase price: US$40.0 million; actual closing purchase price after adjustments: ≈ US$13.66 million.
• Consideration: unsecured, subordinated convertible promissory notes bearing 3.85% annual interest, 5‑year maturity.
• Estimated conversion: notes are estimated to convert into ~22,036,528 Subordinate Voting Shares (pre‑share consolidation) at a deemed price of US$0.62/share, subject to final post‑closing adjustment and Canadian Securities Exchange pricing rules.
• Conversion mechanics: holders may convert on or after the second anniversary of closing; subject to automatic conversion on or after that date per the note terms. Conversion price equals the greater of (i) 20‑day VWAP ending two trading days prior to closing and (ii) US$0.62 (subject to adjustments).
• Post‑closing purchase price adjustments are implemented mainly via changes to the number of shares issuable on conversion (or direct share issuances), not cash escrows.
• Vireo assumed existing indebtedness, including subordinated seller notes, a senior secured loan facility, and issued an additional subordinated “Redemption Note” at closing.
• Investors received piggyback registration rights via Investor Rights Agreements; the Company also issued a press release the same day.

Why It Matters This transaction expands Vireo’s operations into Bridgewell’s agribusiness platform while minimizing immediate cash outlay by issuing convertible notes and taking on the target’s debt. For investors, key implications are potential share dilution (an estimated 22 million shares pre‑adjustment) if the notes convert, additional leverage on Vireo’s balance sheet from assumed debt, and timing risk since conversions may occur beginning two years after closing (and can become automatic thereafter). The use of equity issuance for purchase‑price adjustments means future dilutive issuances are possible rather than cash payments. Registration rights make future resale of converted shares easier for noteholders, which could affect share supply when conversion and resale occur.